25 May 2013
Keywords: japanese, news, brief, amgen/kirin, brewery, co-developed, stem
Article | 02 May 1994
- Amgen/Kirin Brewery's co-developed stem cell factor is to enter a
Phase I study this month, according to Fuminori Yoshida, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 May 1994
24 May 2013
© 2013 thepharmaletter.com